Literature DB >> 11844843

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.

Jan Dörr1, Ingo Bechmann, Sonia Waiczies, Orhan Aktas, Henning Walczak, Peter H Krammer, Robert Nitsch, Frauke Zipp.   

Abstract

Apoptosis mediated by members of the tumor necrosis factor (TNF)-nerve growth factor superfamily plays a crucial role in the interaction of the nervous and the immune system. On the one hand, it is involved in the defense mechanisms of the brain, the immune privilege. On the other hand, it is involved in the induction of glial-neuronal cell death in neuroinflammatory diseases. Here, we show that in contrast to the other known death ligands, TNF-related apoptosis-inducing ligand (TRAIL) is not constitutively expressed in the human brain, whereas both apoptosis-mediating and apoptosis-blocking TRAIL receptors are found on neurons, astrocytes, and oligodendrocytes. Thus, the brain differs from other immune-privileged organs, such as the placenta, with the TRAIL receptor-TRAIL system not being part of the immune privilege of the brain. Conversely, this death receptor-ligand system might well play an important role in T cell-mediated autoimmune diseases of the CNS such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844843      PMCID: PMC6757573     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

Review 1.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.

Authors:  Barbara Cannella; Stefanie Gaupp; Kakuri M Omari; Cedric S Raine
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

3.  Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.

Authors:  Maurizio Mongiat; Giovanni Ligresti; Stefano Marastoni; Erica Lorenzon; Roberto Doliana; Alfonso Colombatti
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

Review 4.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 5.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

6.  Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors.

Authors:  Sarah M Richardson-Burns; Douglas J Kominsky; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

7.  TRAIL limits excessive host immune responses in bacterial meningitis.

Authors:  Olaf Hoffmann; Josef Priller; Timour Prozorovski; Ulf Schulze-Topphoff; Nevena Baeva; Jan D Lunemann; Orhan Aktas; Cordula Mahrhofer; Sarah Stricker; Frauke Zipp; Joerg R Weber
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  TNF-related apoptosis-inducing ligand level in Alzheimer's disease.

Authors:  Sermin Genc; Mehtap Yuksel Egrilmez; Erdem Yaka; Zahide Cavdar; Leyla Iyilikci; Gorsev Yener; Kursad Genc
Journal:  Neurol Sci       Date:  2009-03-18       Impact factor: 3.307

Review 9.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

10.  Human brain astrocytes mediate TRAIL-mediated apoptosis after treatment with IFN-gamma.

Authors:  Jeonggi Lee; Jeon-Soo Shin; In-Hong Choi
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.